Connect to share and comment

Baseball: Halladay set for shoulder surgery

Philadelphia Phillies ace Roy Halladay will have surgery on his pitching shoulder and thinks he could return to the mound this Major League Baseball season, the team said Wednesday. The right-hander, who has an earned run average of 8.65 in seven starts this season, said he'll have an arthroscopic procecure to repair bone spurs, a partially torn rotator cuff and frayed labrum.

Omega-3 acids not beneficial for cardiac risk group: study

Fish oil supplements rich in omega-3 fatty acids are not beneficial for patients at high risk of cardiovascular troubles and already being medicated, a study found Wednesday. In the study, carried out in 2010 in Italy with 12,513 patients, half the group took an omega-3 supplement and the other half an olive oil placebo. Previous clinical trials have suggested that these supplements could reduce cardiovascular risks for patients suffering from cardiovascular disease or who have already suffered cardiac arrest.

Push to promote coca-based food by Bolivia's president fails to win over palates

VILLA TUNARI, Bolivia - Since taking office seven years ago, President Evo Morales has tried to persuade the world that he has no tolerance for cocaine and that Bolivia's thousands of acres of coca plants can be dedicated to such traditional uses as fighting fatigue as well as whipping up wholesome treats like sweet breads and coca puffed snacks.

Merck, Glaxo health groups bringing cervical cancer vaccines to girls in poorest countries

GENEVA - Two multinational drugmakers are teaming up with global health groups in an attempt to protect millions of girls in the world's poorest countries from deadly cervical cancer. Starting with pilot programs in eight Asian and African nations, the ambitious project aims to inoculate more than 30 million girls in more than 40 countries by 2020. The endeavour was announced Thursday by the GAVI Alliance, a public-private partnership that's worked with drugmakers to deliver vaccines to treat fatal childhood illnesses in the world's most impoverished regions.

Canada not planning H7N9 bird flu vaccine studies; will watch US results: PHAC

TORONTO - Canada currently has no plans to ask its pandemic flu vaccine manufacturers to make trial batches of vaccine to protect against the new H7N9 bird flu, senior officials of the Public Health Agency of Canada have revealed. While the U.S. government has said it will ask several of flu vaccine manufacturers to start growing up batches of serum against the new virus this summer, Canada will watch, wait and learn from the work the U.S. does, the officials said in an interview with The Canadian Press.

Government, pharmacists reach one-year deal in Saskatchewan

REGINA - The Saskatchewan government has reached a deal with pharmacists aimed at reducing the impact of lower generic drug costs. The one-year agreement increases drug dispensing fees by 50 cents to $10.75 per prescription. It also restructures a program for pharmacies that receive an annual fee for services to seniors with chronic conditions. Pharmacists will also be compensated for costs related to work they do to help people stop smoking — costs pharmacists have up to now incurred.

Merck, Glaxo health groups bringing cervical cancer vaccines to girls in poorest countries

TRENTON, N.J. - Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. Starting with pilot programs in eight Asian and African nations, the ambitious project ultimately is intended to inoculate more than 30 million girls in more than 40 countries by 2020. Given that most women killed by cervical cancer live in developing countries, the project could have a huge impact.

'Garbage man' in cells could extend life

A gene that acts like a garbage man to clean up old material in the cells boosted the life spans of fruit flies and may offer new paths in the fight against human aging, US researchers said Monday. When researchers manipulated the neurons of fruit flies to contain higher levels of the gene, known as parkin, they lived 28 percent longer and remained healthy, said the study in the Proceedings of the National Academy of Sciences.

FDA is reviewing drugmaker Merck's immune therapy tablet for gradually easing ragweed allergy

WHITEHOUSE STATION, N.J. - Drugmaker Merck Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year. It could become an alternative to months of uncomfortable allergy shots. Both methods gradually desensitize the immune system to the substance triggering the allergic reaction. In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy tablet for grass pollen allergies.

Toss your toothbrush after a sore throat? Maybe not

Logic predicts that tossing a toothbrush after a bout of strep throat is a good idea, but a new study finds that it's perhaps not necessary.
Syndicate content